GM1 Gangliosidosis (also known
as Norman-Landing Disease) is caused by a deficiency in acid beta-galactosidase-1
and results in the accumulation of ganglioside in the tissues. As
with many Lysosomal Storage Diseases, there are three types of GM1 Gangliosidosis
characterized by the age of onset. The infantile form of the disease
may be evident at birth or shortly thereafter and presents with organomegaly
(enlarged organs, typically the liver and spleen), dysostosis (abnormal
bone formation), coarsened facial features and rapid neurologic deterioration.
Death typically occurs during the second year of life from recurrent infection
or heart failure.
The juvenile form of GM1 Gangliosidosis usually presents by two years of
age and is characterized by progressive psychomotor retardation and symptoms
similar to the infantile form, though less severe. Those afflicted
with the juvenile form generally die before the second decade of life.
The adult form presents during childhood or adolescence as a slowly progressive
dementia with Parkinsonian features. The age of death from the adult
form varies greatly from case to case.